These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1084 related items for PubMed ID: 16941249

  • 21. Accuracy of serum pepsinogens I and II, gastrin-17 and anti-helicobacter pylori antibodies in histological diagnoses of atrophic gastritis.
    Irvani S, Hashemi MR, Moghadam KG, Saeidee S, Khavaran K, Najari O, Ranavardi M, Nasiri S, Salmasian H, Rohanizadegan M.
    Minerva Gastroenterol Dietol; 2010 Mar; 56(1):13-7. PubMed ID: 20190719
    [Abstract] [Full Text] [Related]

  • 22. [Investigation about usefulness of serum antibody of Helicobacter pylori and serum pepsinogen I/II ratio as a marker of the judgment after eradication therapy].
    Fujisawa T, Kumagai T, Goto A, Fujimori K, Akamatsu T, Kiyosawa K.
    Nihon Rinsho; 1999 Jan; 57(1):101-6. PubMed ID: 10036944
    [Abstract] [Full Text] [Related]

  • 23. Diagnosis of Helicobacter pylori-induced gastritis by serum pepsinogen levels.
    Kitamura Y, Yoshihara M, Ito M, Boda T, Matsuo T, Kotachi T, Tanaka S, Chayama K.
    J Gastroenterol Hepatol; 2015 Oct; 30(10):1473-7. PubMed ID: 25974661
    [Abstract] [Full Text] [Related]

  • 24. Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacterpylori antibodies in the management of dyspeptic patients in primary care.
    Germaná B, Di Mario F, Cavallaro LG, Moussa AM, Lecis P, Liatoupolou S, Comparato G, Carloni C, Bertiato G, Battiestel M, Papa N, Aragona G, Cavestro GM, Iori V, Merli R, Bertolini S, Caruana P, Franzé A.
    Dig Liver Dis; 2005 Jul; 37(7):501-8. PubMed ID: 15975537
    [Abstract] [Full Text] [Related]

  • 25. Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodies.
    Al-Assi MT, Miki K, Walsh JH, Graham DP, Asaka M, Graham DY.
    Am J Gastroenterol; 1999 Sep; 94(9):2367-72. PubMed ID: 10483993
    [Abstract] [Full Text] [Related]

  • 26. Chronic atrophic gastritis and Helicobacter pylori infection in primary biliary cirrhosis: a cross-sectional study with matching.
    Floreani A, Biagini MR, Zappalà F, Farinati F, Plebani M, Rugge M, Surrenti C, Naccarato R.
    Ital J Gastroenterol Hepatol; 1997 Feb; 29(1):13-7. PubMed ID: 9265572
    [Abstract] [Full Text] [Related]

  • 27. Long-term strict monitoring of plasma ghrelin and other serological markers of gastric diseases after Helicobacter pylori eradication.
    Masaoka T, Suzuki H, Imaeda H, Hosoda H, Ohara T, Morishita T, Ishii H, Kangawa K, Hibi T.
    Hepatogastroenterology; 2005 Feb; 52(61):1-4. PubMed ID: 15782980
    [Abstract] [Full Text] [Related]

  • 28. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
    Sasazuki S, Inoue M, Iwasaki M, Otani T, Yamamoto S, Ikeda S, Hanaoka T, Tsugane S, Japan Public Health Center Study Group.
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
    [Abstract] [Full Text] [Related]

  • 29. Normalization of pH level and gastric mucosa after eradication of H. pylori in the remnant stomach.
    Kato S, Matsukura N, Matsuda N, Tsuchiya S, Naito Z, Tajiri T.
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S258-61. PubMed ID: 19120908
    [Abstract] [Full Text] [Related]

  • 30. Decrease of serum total ghrelin in extensive atrophic gastritis: comparison with pepsinogens in histological reference.
    Eun Bae S, Hoon Lee J, Soo Park Y, Ok Kim S, Young Choi J, Yong Ahn J, Hoon Kim D, Don Choi K, June Song H, Hyug Lee G, Choe J, Jin Jang S, Jung HY.
    Scand J Gastroenterol; 2016 Dec; 51(2):137-44. PubMed ID: 26513345
    [Abstract] [Full Text] [Related]

  • 31. Performance of routine Helicobacter pylori tests in patients with atrophic gastritis.
    Sudraba A, Daugule I, Rudzite D, Funka K, Tolmanis I, Engstrand L, Janciauskas D, Jonaitis L, Kiudelis G, Kupcinskas L, Ivanauskas A, Leja M.
    J Gastrointestin Liver Dis; 2011 Dec; 20(4):349-54. PubMed ID: 22187698
    [Abstract] [Full Text] [Related]

  • 32. Helicobacter pylori infection, but not mucosal atrophy, significantly affects serum pepsinogen level after gastric cancer surgery.
    Onoda N, Katsuragi K, Maeda K, Sawada T, Wakasa K, Hirakawa K.
    Hepatogastroenterology; 2006 Dec; 53(70):619-23. PubMed ID: 16995475
    [Abstract] [Full Text] [Related]

  • 33. Migrant communities constitute a possible target population for primary prevention of Helicobacter pylori-related complications in low incidence countries.
    De Vries AC, Van Driel HF, Richardus JH, Ouwendijk M, Van Vuuren AJ, De Man RA, Kuipers EJ.
    Scand J Gastroenterol; 2008 Dec; 43(4):403-9. PubMed ID: 18365904
    [Abstract] [Full Text] [Related]

  • 34. Problem of distinguishing false-positive tests from acute or transient Helicobacter pylori infections.
    Nurgalieva ZZ, Opekun AR, Graham DY.
    Helicobacter; 2006 Apr; 11(2):69-74. PubMed ID: 16579835
    [Abstract] [Full Text] [Related]

  • 35. IL-1beta and IL-8, matrix metalloproteinase 3, and pepsinogen secretion before and after H. pylori eradication in gastroduodenal phenotypes.
    Chang YW, Oh HC, Jang JY, Hwangbo Y, Lee JW, Lee HJ, Joo KR, Dong SH, Kim SS, Kim HJ, Kim BH, Chang R.
    Scand J Gastroenterol; 2008 Apr; 43(10):1184-93. PubMed ID: 18609140
    [Abstract] [Full Text] [Related]

  • 36. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
    Ghoshal UC, Kumar S, Krishnani N, Kumari N, Chourasia D, Tripathi S.
    Trop Gastroenterol; 2011 Apr; 32(4):292-8. PubMed ID: 22696910
    [Abstract] [Full Text] [Related]

  • 37. Helicobacter pylori infection and chronic atrophic gastritis: associations according to severity of disease.
    Weck MN, Gao L, Brenner H.
    Epidemiology; 2009 Jul; 20(4):569-74. PubMed ID: 19404195
    [Abstract] [Full Text] [Related]

  • 38. The optimal serum pepsinogen cut-off value for predicting histologically confirmed atrophic gastritis.
    Kim EH, Kang H, Park CH, Choi HS, Jung DH, Chung H, Park JC, Shin SK, Lee SK, Lee YC.
    Dig Liver Dis; 2015 Aug; 47(8):663-8. PubMed ID: 26077884
    [Abstract] [Full Text] [Related]

  • 39. Non-endoscopic diagnosis of multifocal atrophic gastritis; efficacy of serum gastrin-17, pepsinogens and Helicobacter pylori antibodies.
    Hartleb M, Wandzel P, Waluga M, Matyszczyk B, Bołdys H, Romañczyk T.
    Acta Gastroenterol Belg; 2004 Aug; 67(4):320-6. PubMed ID: 15727075
    [Abstract] [Full Text] [Related]

  • 40. Value of serology (ELISA) for the diagnosis of Helicobacter pylori infection: evaluation in patients attending endoscopy and in those with fundic atrophic gastritis.
    Tucci A, Poli L, Donati M, Mazzoni C, Cevenini R, Sambri V, Varoli O, Bocus P, Ferrari A, Paparo GF, Caletti G.
    Ital J Gastroenterol; 1996 Sep; 28(7):371-6. PubMed ID: 8937937
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 55.